Plante Moran Financial Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-137
| Closed | -$1K | – | 848 |
|
|
2019
Q4 | $1K | Hold |
137
| – | – | ﹤0.01% | 729 |
|
|
2019
Q3 | $1K | Hold |
137
| – | – | ﹤0.01% | 825 |
|
|
2019
Q2 | $1K | Hold |
137
| – | – | ﹤0.01% | 763 |
|
|
2019
Q1 | $2K | Hold |
137
| – | – | ﹤0.01% | 723 |
|
|
2018
Q4 | $2K | Hold |
137
| – | – | ﹤0.01% | 748 |
|
|
2018
Q3 | $3K | Hold |
137
| – | – | ﹤0.01% | 656 |
|
|
2018
Q2 | $3K | Sell |
137
-85
| -38% | -$1.86K | ﹤0.01% | 688 |
|
|
2018
Q1 | $4K | Buy |
222
+85
| +62% | +$1.53K | ﹤0.01% | 761 |
|
|
2017
Q4 | $3K | Hold |
137
| – | – | ﹤0.01% | 767 |
|
|
2017
Q3 | $2K | Hold |
137
| – | – | ﹤0.01% | 736 |
|
|
2017
Q2 | $5K | Hold |
137
| – | – | ﹤0.01% | 670 |
|
|
2017
Q1 | $4K | Sell |
137
-720
| -84% | -$21K | ﹤0.01% | 735 |
|
|
2016
Q4 | $31K | Buy |
857
+137
| +19% | +$4.96K | 0.02% | 408 |
|
|
2016
Q3 | $33K | Sell |
720
-72
| -9% | -$3.3K | 0.02% | 395 |
|
|
2016
Q2 | $40K | Buy |
792
+677
| +589% | +$34.2K | 0.03% | 325 |
|
|
2016
Q1 | $6K | Buy |
+115
| New | +$6K | ﹤0.01% | 565 |
|
|
2014
Q3 | – | Sell |
-250
| Closed | -$13K | – | 849 |
|
|
2014
Q2 | $13K | Hold |
250
| – | – | 0.01% | 463 |
|
|
2014
Q1 | $13K | Sell |
250
-83
| -25% | -$4.32K | 0.01% | 314 |
|
|
2013
Q4 | $13K | Buy |
333
+83
| +33% | +$3.24K | 0.01% | 410 |
|
|
2013
Q3 | $9K | Hold |
250
| – | – | 0.01% | 404 |
|
|
2013
Q2 | $10K | Buy |
+250
| New | +$10K | 0.01% | 352 |
|